<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方 | wechat-feeds</title><link>http://MzA4MDA4MTIzMg.favicon.privacyhide.com/favicon.ico</link><description>世事洞明皆学问，人情练达即文章</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 25 May 2021 10:33:07 +0800</pubDate><image><url>http://MzA4MDA4MTIzMg.favicon.privacyhide.com/favicon.ico</url><title>医药魔方 | wechat-feeds</title><link>http://MzA4MDA4MTIzMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>德琪医药梅建明：创新靶点稀缺是全球困境，引进新药项目瞄准同类首个</title><link>https://mp.weixin.qq.com/s/_int7dxAnIKEqoOanf1GEQ</link><description></description><content:encoded><![CDATA[德琪医药梅建明：创新靶点稀缺是全球困境，引进新药项目瞄准同类首个]]></content:encoded><pubDate>Tue, 25 May 2021 07:42:46 +0800</pubDate></item><item><title>倒计时一周！红杉中国智能医疗基因组学孵化器火热开启，这6类公司请注意！</title><link>https://mp.weixin.qq.com/s/poqhbYas0sDupKIC8oNmCg</link><description></description><content:encoded><![CDATA[倒计时一周！红杉中国智能医疗基因组学孵化器火热开启，这6类公司请注意！]]></content:encoded><pubDate>Tue, 25 May 2021 07:42:46 +0800</pubDate></item><item><title>【开幕倒计时】第七届PharmaCon小分子创新药技术盛宴，完整议程精彩亮相！</title><link>https://mp.weixin.qq.com/s/GGvhz6sMUbRl_BkJFFOQ8g</link><description></description><content:encoded><![CDATA[【开幕倒计时】第七届PharmaCon小分子创新药技术盛宴，完整议程精彩亮相！]]></content:encoded><pubDate>Tue, 25 May 2021 07:42:46 +0800</pubDate></item><item><title>德琪医药任命Kathryn Gregory为副总裁兼商务拓展负责人</title><link>https://mp.weixin.qq.com/s/ps73HucCVkDL19Svz9jeDA</link><description></description><content:encoded><![CDATA[德琪医药任命Kathryn Gregory为副总裁兼商务拓展负责人]]></content:encoded><pubDate>Tue, 25 May 2021 07:42:46 +0800</pubDate></item><item><title>一代巨头Sigma-Aldrich的成功之路和启示</title><link>https://mp.weixin.qq.com/s/juG6KTZB43byuSsWYTRyIQ</link><description></description><content:encoded><![CDATA[一代巨头Sigma-Aldrich的成功之路和启示]]></content:encoded><pubDate>Mon, 24 May 2021 07:25:10 +0800</pubDate></item><item><title>一箭双雕！胰腺癌新靶点SLC7A11：突破胰腺癌防御堡垒“潜力军”</title><link>https://mp.weixin.qq.com/s/tM0TvTzbsJTbl4_CuROumA</link><description></description><content:encoded><![CDATA[一箭双雕！胰腺癌新靶点SLC7A11：突破胰腺癌防御堡垒“潜力军”]]></content:encoded><pubDate>Mon, 24 May 2021 07:25:10 +0800</pubDate></item><item><title>难而正确：从左晖到中国创新药</title><link>https://mp.weixin.qq.com/s/dy_F3n504xcv8ht0JysjvA</link><description></description><content:encoded><![CDATA[难而正确：从左晖到中国创新药]]></content:encoded><pubDate>Sun, 23 May 2021 08:36:15 +0800</pubDate></item><item><title>吕明方：遇见他人，其实是遇见自己</title><link>https://mp.weixin.qq.com/s/_BmgXwSjvfRuNQ1vfqtLOw</link><description></description><content:encoded><![CDATA[吕明方：遇见他人，其实是遇见自己]]></content:encoded><pubDate>Sun, 23 May 2021 08:36:15 +0800</pubDate></item><item><title>7月课程 | 医药商务拓展与对外合作之BD实用基础</title><link>https://mp.weixin.qq.com/s/e40K2qGh0_-ovXNpCMSk0g</link><description></description><content:encoded><![CDATA[7月课程 | 医药商务拓展与对外合作之BD实用基础]]></content:encoded><pubDate>Sun, 23 May 2021 08:36:15 +0800</pubDate></item><item><title>创响王健：出生卑微，梦想远大</title><link>https://mp.weixin.qq.com/s/sK4SyKJyTEHJB4UqKxderA</link><description></description><content:encoded><![CDATA[创响王健：出生卑微，梦想远大]]></content:encoded><pubDate>Sat, 22 May 2021 07:27:34 +0800</pubDate></item><item><title>强生EGFR/c-Met双抗获FDA加速批准</title><link>https://mp.weixin.qq.com/s/LuZE3MWIhnqWld7L9ifj1Q</link><description></description><content:encoded><![CDATA[强生EGFR/c-Met双抗获FDA加速批准]]></content:encoded><pubDate>Sat, 22 May 2021 07:27:34 +0800</pubDate></item><item><title>恒瑞原研闪耀世界舞台，多项重磅研究入围ASCO年会Oral环节</title><link>https://mp.weixin.qq.com/s/HGU5zy8QlYnjZ9X3mDeNKA</link><description></description><content:encoded><![CDATA[恒瑞原研闪耀世界舞台，多项重磅研究入围ASCO年会Oral环节]]></content:encoded><pubDate>Sat, 22 May 2021 07:27:34 +0800</pubDate></item><item><title>ASCO2021点评：晚期肺癌“炒冷饭”，早中期肺癌“有突破”</title><link>https://mp.weixin.qq.com/s/QGYsBBP4PyzoY4ejgnWYOw</link><description></description><content:encoded><![CDATA[ASCO2021点评：晚期肺癌“炒冷饭”，早中期肺癌“有突破”]]></content:encoded><pubDate>Fri, 21 May 2021 08:00:54 +0800</pubDate></item><item><title>康宁杰瑞将在ASCO 2021大会上公布多项临床研究数据</title><link>https://mp.weixin.qq.com/s/L2Li8nC8-6QtQezVC_DxJQ</link><description></description><content:encoded><![CDATA[康宁杰瑞将在ASCO 2021大会上公布多项临床研究数据]]></content:encoded><pubDate>Fri, 21 May 2021 08:00:54 +0800</pubDate></item><item><title>MICOT（麦科奥特）完成3.6亿元B轮融资，加速推进双功能多肽药物开发</title><link>https://mp.weixin.qq.com/s/iGdvuZgYZ9qdGaQY6KANKQ</link><description></description><content:encoded><![CDATA[MICOT（麦科奥特）完成3.6亿元B轮融资，加速推进双功能多肽药物开发]]></content:encoded><pubDate>Fri, 21 May 2021 08:00:54 +0800</pubDate></item><item><title>医药魔方招聘：媒体商务专员/主管</title><link>https://mp.weixin.qq.com/s/q2ymR-QqqhyCdqvTcRYTkw</link><description></description><content:encoded><![CDATA[医药魔方招聘：媒体商务专员/主管]]></content:encoded><pubDate>Fri, 21 May 2021 08:00:54 +0800</pubDate></item><item><title>ASCO2021摘要精选50篇</title><link>https://mp.weixin.qq.com/s/F6RE_FNfyaVu3IE3TdRTQA</link><description></description><content:encoded><![CDATA[ASCO2021摘要精选50篇]]></content:encoded><pubDate>Thu, 20 May 2021 08:05:59 +0800</pubDate></item><item><title>阿诺医药向FDA递交口服PD-L1抑制剂AN4005临床试验申请</title><link>https://mp.weixin.qq.com/s/PhMd8kqbuZLUA1ojexSwSw</link><description></description><content:encoded><![CDATA[阿诺医药向FDA递交口服PD-L1抑制剂AN4005临床试验申请]]></content:encoded><pubDate>Thu, 20 May 2021 08:05:59 +0800</pubDate></item><item><title>全球肿瘤新药重磅临床进展 | 2021年4月</title><link>https://mp.weixin.qq.com/s/HIk7f1wl__Lcqa-25L49bw</link><description></description><content:encoded><![CDATA[全球肿瘤新药重磅临床进展 | 2021年4月]]></content:encoded><pubDate>Thu, 20 May 2021 08:05:59 +0800</pubDate></item><item><title>全新课程 | 如何全方位做好医学监查</title><link>https://mp.weixin.qq.com/s/IGxqdvG3iBvjtWtMdf1PZQ</link><description></description><content:encoded><![CDATA[全新课程 | 如何全方位做好医学监查]]></content:encoded><pubDate>Thu, 20 May 2021 08:05:59 +0800</pubDate></item></channel></rss>